$ Value
—
Shares
31,840
Price
—
Filed
Jan 7
Insider
Name
Nieuwkoop Jeroen
Title
Chief Operating Officer
CIK
0001955369
Roles
Transaction Details
Transaction Date
2025-12-04
Code
J
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
31,840
Footnotes
On December 2, 2025, Hyperliquid Strategies Inc (the "Company") completed its previously announced business combination (the "Closing"), pursuant to the Business Combination Agreement, dated as of July 11, 2025 (as amended on September 22, 2025, the "BCA"), by and among the Company, Sonnet BioTherapeutics Holdings, Inc. ("Sonnet"), Rorschach I LLC, TBS Merger Sub Inc. and Rorschach Merger Sub, LLC . In connection with the Closing, Rorschach Capital LLC received an aggregate of 6,580,800 shares of common stock, par value $0.01 per share, of the Company (the "Common Stock"). On December 4, 2025, Rorschach Capital LLC distributed 31,840 shares of Common Stock to Mr. Nieuwkoop, a member of Rorschach Capital LLC.
Filing Info
Nieuwkoop Jeroen's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-04 | PURR | J | — |
Other Insiders at PURR (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| LEIBOWITZ LAWRENCE E | — | — | 2026-04-01 |
|
Schamis David Ira
CEO
|
— | — | 2026-02-09 |
| Diamond Robert E. Jr. | — | — | 2026-02-09 |
| Dyrness Albert D. | — | — | 2026-02-09 |
| TUDER JEFFREY | — | — | 2026-02-09 |
| KING THOMAS C. | — | — | 2026-04-01 |
| Bhatt Nailesh | — | — | 2026-04-01 |
| Rosengren Eric S | — | — | 2026-04-01 |